Cargando…

Impacts of CA9 Gene Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Characteristics in Taiwan

BACKGROUND: Carbonic anhydrase 9 (CA9) is reportedly overexpressed in several types of carcinomas and is generally considered a marker of malignancy. The current study explored the effect of CA9 gene polymorphisms on the susceptibility of developing urothelial cell carcinoma (UCC) and the clinicopat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shian-Shiang, Liu, Yu-Fan, Ou, Yen-Chuan, Chen, Chuan-Shu, Li, Jian-Ri, Yang, Shun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862582/ https://www.ncbi.nlm.nih.gov/pubmed/24349364 http://dx.doi.org/10.1371/journal.pone.0082804

Ejemplares similares

The impacts of MACC1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan
por: Chang, Li-Wen, et al.
Publicado: (2023)

Effect of HMGB1 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathological Characteristics
por: Hung, Sheng-Chun, et al.
Publicado: (2018)

Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics
por: Lin, Chia-Yen, et al.
Publicado: (2019)

Impact of H19 Polymorphisms on Prostate Cancer Clinicopathologic Characteristics
por: Hu, Ju-Chuan, et al.
Publicado: (2020)

Impacts of CA9 Gene Polymorphisms and Environmental Factors on Oral-Cancer Susceptibility and Clinicopathologic Characteristics in Taiwan
por: Chien, Ming-Hsien, et al.
Publicado: (2012)

Impact of EZH2 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Features
por: Yu, Yung-Luen, et al.
Publicado: (2014)

Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma
por: Tsay, Ming-Dow, et al.
Publicado: (2019)

The impact of receptor of advanced glycation end‐products polymorphisms on prostate cancer progression and clinicopathological characteristics
por: Chou, Ying‐Erh, et al.
Publicado: (2021)

Impact of Long Non-Coding RNA HOTAIR Genetic Variants on the Susceptibility and Clinicopathologic Characteristics of Patients with Urothelial Cell Carcinoma
por: Tung, Min-Che, et al.
Publicado: (2019)

Associations of VEGF-C Genetic Polymorphisms with Urothelial Cell Carcinoma Susceptibility Differ between Smokers and Non-Smokers in Taiwan
por: Tung, Min-Che, et al.
Publicado: (2014)

Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma
por: Weng, Wei-Chun, et al.
Publicado: (2023)

Impact of Gene Polymorphisms in GAS5 on Urothelial Cell Carcinoma Development and Clinical Characteristics
por: Weng, Wei-Chun, et al.
Publicado: (2020)

Geriatric nutritional risk index as a prognostic marker for patients with upper tract urothelial carcinoma receiving radical nephroureterectomy
por: Chang, Li-Wen, et al.
Publicado: (2023)

Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer
por: Hsieh, Chun-Yu, et al.
Publicado: (2020)

WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy
por: Lin, Chia-Yen, et al.
Publicado: (2023)

Associations between LncRNA MALAT1 Polymorphisms and Lymph Node Metastasis in Prostate Cancer
por: Hu, Ju-Chuan, et al.
Publicado: (2021)

Genetic Variations of Melatonin Receptor Type 1A are Associated with the Clinicopathologic Development of Urothelial Cell Carcinoma
por: Lin, Yung-Wei, et al.
Publicado: (2017)

Impacts of AURKA Genetic Polymorphism on Urothelial Cell Carcinoma Development
por: Huang, Chia-Hung, et al.
Publicado: (2019)

Tumor Multifocality is a Significant Risk Factor of Urinary Bladder Recurrence after Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Institutional Study
por: Chen, Chuan-Shu, et al.
Publicado: (2020)

Impact of Clinicopathological Characteristics and Tissue Inhibitor of Metalloproteinase-3 Polymorphism Rs9619311 on Biochemical Recurrence in Taiwanese Patients with Prostate Cancer
por: Hsieh, Chun-Yu, et al.
Publicado: (2022)

Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: the Taiwan Robot Urological Surgery Team (TRUST) experience
por: Yang, Chen-Kuang, et al.
Publicado: (2014)

The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics
por: Chou, Ying-Erh, et al.
Publicado: (2020)

Dopamine receptor D2 genetic variations is associated with the risk and clinicopathological variables of urothelial cell carcinoma in a Taiwanese population
por: Tung, Min-Che, et al.
Publicado: (2018)

Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics
por: Li, Chien-Chang, et al.
Publicado: (2020)

CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chou, Ying-Erh, et al.
Publicado: (2014)

Effects of Long Noncoding RNA H19 Polymorphisms on Urothelial Cell Carcinoma Development
por: Yang, Po-Jen, et al.
Publicado: (2019)

Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan
por: Chung, Jui-Fu, et al.
Publicado: (2022)

Effect of WW Domain-Containing Oxidoreductase Gene Polymorphism on Clinicopathological Characteristics of Patients with EGFR Mutant Lung Adenocarcinoma in Taiwan
por: Li, Ju-Pi, et al.
Publicado: (2021)

The prognostic impact of lymph node dissection for clinically node-negative upper urinary tract urothelial carcinoma in patients who are treated with radical nephroureterectomy
por: Hsieh, Hsiang-Chen, et al.
Publicado: (2022)

Effect of RECK Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chung, Tsung-Te, et al.
Publicado: (2012)

CD44 Gene Polymorphisms as a Risk Factor for Susceptibility and Their Effect on the Clinicopathological Characteristics of Lung Adenocarcinoma in Male Patients
por: Li, Ju-Pi, et al.
Publicado: (2020)

CD44 Gene Polymorphisms and Environmental Factors on Oral Cancer Susceptibility in Taiwan
por: Chou, Ying-Erh, et al.
Publicado: (2014)

Real world treatment sequences and outcomes for metastatic renal cell carcinoma
por: Lai, Gu-Shun, et al.
Publicado: (2023)

Genetic Associations of Visfatin Polymorphisms with EGFR Status and Clinicopathologic Characteristics in Lung Adenocarcinoma
por: Chang, Sunny Li-Yun, et al.
Publicado: (2022)

The impact of FOXP3 polymorphisms on oral cancer progression and clinicopathological characteristics
por: Chen, Ping-Ju, et al.
Publicado: (2023)

Impact of microRNA-34a and polymorphism of its target gene CA9 on susceptibility to uterine cervical cancer
por: Yang, Shun-Fa, et al.
Publicado: (2017)

Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features
por: Cheng, Chao-Wen, et al.
Publicado: (2013)

Impact of VEGF-C Gene Polymorphisms and Environmental Factors on Oral Cancer Susceptibility in Taiwan
por: Chien, Ming-Hsien, et al.
Publicado: (2013)

The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer Progression and Clinicopathological Characteristics
por: Huang, Hsien-Cheng, et al.
Publicado: (2022)

Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer
por: Wen, Yu‐Ching, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t7qspq80h9v3cbnhrnovhksg80